chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt given vaccine for travel. Clinic hot & humid. Client did not eat bfast prior to vaccines. At checkout pt c/o dizziness, nausea, sweating - clinic rm, ice pack back of neck, feet up, supine position, after recover pt given apple juice -> home with father to get food.
Started with cough, mild shortness of breath and feeling terrible  in evening of 1/19.
SIRVA Shoulder Injury from Vaccine. Flu shot in right arm was administered high on the deltoid. Hurt a great deal. Followed a few hours later with intense pain and limited range of motion that interfered with daily activity. Continuing for 8 days, with lessening pain and gradual increased ROM. Took Advil and applied warm compresses on Day 2.
I felt like I had pulled a muscle, the pelvic muscle, but I haven't did anything. Went to the doctor and stated it was sore muscle.
Patient states she developed Rash and Eczema exacerbation a few days around 10/23/22 after vaccination.  Patient did not report to provider until 11/8/22.  Rash resolved but Eczema exacerbation still an issue.  Patient has a dermatologist who treats are skin issues and was seen in Dermatologist office 10 days before vaccination for atopic dermatitis follow up.
Flu-like symptoms, nausea, aching muscles, stiff joints, could barely get out of bed the next day after the vaccine. The following week on 3/23 I had severe cellulitis only in the area of where I receieved the vaccine in my arm. Was given atibiotics.
Waited the required 15 minutes after vaccine and done just fine. Started my drive back home and about 15 minutes into my drive I began feeling very funny in my head, my heart rate went sky high, started shaking all over my body. Could barely drive called 911. Was advised to pull over and await for ambulance. Ended up at ER with elevated heart rate, chest pain and feeling winded. I could breath ok no swelling in throat but just felt like a elephant was on my chest
This spontaneous report was received from a other health professional refers to a patient of unknown age and gender. On 17-DEC2014 the patient was vaccinated with ZOSTAVAX lot # J014851, subcutaneous. On 17-DEC-2014 the patient was vaccinated with expired ZOSTAVAX. No AE was reported. The outcome is unknown. Additional information has been requested.
Initial report received from a healthcare professional on 25 JUNE 2013. A 61-year-old male patient had received an intramuscular dose of ADACEL (batch number: C4365AA, dose number and site of administration not reported) left side (site was not specified) on 12 JUNE 2013. The patient had no illness at the time of vaccination. The patient had medical history of DM (diabetes mellitus), HTN (hypertension) and Hyperlipidemia. On 13 JUNE 2013, one day after vaccination, the patient experienced swollen, stiff and painful hands. Laboratory tests were not done and corrective treatments were not reported. The patient required ER/doctor visit as he felt that it was getting worse. As of 25 JUNE 2013, the patient had not recovered from the events. List of documents held by sender: none
tingling; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 23-Mar-2021 and was forwarded to Moderna on 23-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     The patient's past medical history included Diabetes, Rib fracture in October 2020 and Muscle disorder in January 2020. Concomitant products included TRAMADOL for Back pain and Muscle pain, WARFARIN, ATORVASTATIN, INSULIN ASPART (NOVOLOG), INSULIN DETEMIR (LEVEMIR) and VITAMIN D3 for an unknown indication.    On 19-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced PARAESTHESIA (tingling). At the time of the report, PARAESTHESIA (tingling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Upon internal review on 24-May-2021, age was corrected to unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
1537 post vaccination of additional dose, patient reported ears ringing, headache, and presented with pallor. vaccination nurse called for EMS & NP.  EMS assisted resident to floor on pad with legs raised on chair. Informed that resident was experiencing anxiety prior to vaccine and happens during blood draws. No SOB, no pain, no swelling.  1540 bp 119/70 hr 88 pox 100%  1544 color returning to face and lips and patient reports feeling better 1545 able to sit up and drink water. BP 129/78 hr 95. pt reports no longer feeling lightheaded.  1550 pt eating chips and water. maintained seated on floor matt with no report of weakness. 1551 able to stand and walk to observation without a problem. pt waited another 15 minutes outside. cleared by NP. 1404 left ambulatory accompanied by NP to car.
Vaccine administered 2:30 pm March 4, 2021, March 6, 6:30 a.m. RIGHT hand was red and swollen could not make a fist,  Pain, in hand, wrist and elbow.  March 7, 6:30 a.m. Improving.  March 7, 4:30 PM could make a fist. March 8, 6:30 a.m. appears normal.
Patient face started swelling within an hour of recieving vaccines and started with a temperature at 10:00 PM that night. Mom administered 2.5 ml of Tylenol to patient at 10:00 PM. Mom administered Tylenol every four hours. On 08/25/2015 at 8:45 AM patient temperature 102.5 and mom administered 2.5ml Tylenol. Mom called pediatrician office and patient could not be seen that day. Pediatrician advised mom to take patient to Urgent Care or ER. Mom took patient to ER where he was assessed. ER administered patient Tylenol and Benadryl and sent home. ER ordered mom to see pediatrician and follow up with allergist. Patient to be seen week of August 31, 2015 and doctor will then refer to an allergist before next round of vaccines.
Information has been received from a nurse for Merck Pregnancy Registry concerning a female who in February 2008, was vaccinated with the second dose of Gardasil while she was pregnant.  Now she is experiencing bleeding.  Unknown medical attention was sought. Patient outcome was unknown.  No product quality complaint was involved.  Additional information has been requested.
Received injection 6/22/18 and noticed symptoms 6/24/18. At the injections site skin was red and tender. Patient was advised to ice the site at the time of injection and had not done so but would do it now. Advised patient to watch for worsening of symptoms of if unresolved to seek medical attention. Patient stated that she has an appointment with her PCP this coming week and will inform her of the reaction and have her evaluate the injection site.
Pt devel fever of 104 R w/in 3 hrs of receiving DTP/HIB #3; was irritable & fussy; no sz activity noted; crying off & on-not high pitched was seen @ ER; WBC-WNL;
Child unable to sleep during the night.  Waking up every hour complaining.  Next morning, was able to identify one open sore under tongue approx. 3/4 inch in diameter and also noticed some [[name]] white spots on inside of right cheek.  By Thursday, we noticed a second large open sore under the tongue and some [[name]] spots/perhaps blisters (but [[name]]) on her left big toe and second toe of her left foot (perhaps 10-12 spots).  Contacted doctor who at first thought it may be just a canker sore, but now that we have seen some spots on the foot, we are wondering if it may be Hand/Foot/Mouth disease.  If it is the latter, it seems to be a very mild [[name]] compared to some of pictures I've seen on the Internet.  In any [[name]], my daughter is extremely uncomfortable.  The sores in her mouth are very painful to her.  Whether its canker sores or HFM disease, we've been told that there's nothing we can really do beyond keeping her hydrated.  I just find the timing on onset kind of suspicious given that Hand/Foot/Mouth and H1N1 can both be traced to livestock.
tingling of tongue & lips w/burning of entire mouth & throat, burning of face & tips of ears;improved for a few wk & on the 4SEP95 had a reoccurrence of all sx,  primarily a sensation in throat like a fever blister breaking out;had seen 7 M
1/2 dollar sized lump at inj site. C/O itchiness, warm to touch.
This case was reported by a healthcare professional and described the occurrence of nausea in a 25-year-old female subject who was vaccinated with BOOSTRIX (GlaxoSmithKline). Concurrent medications included birth control. On 11 January 2010 the subject received unspecified dose of BOOSTRIX (.5 ml, unknown). On 11 January 2010, less than one day after vaccination with BOOSTRIX, the subject experienced nausea and diarrhea. The healthcare professional considered the events were disabling, life threatening and clinically significant (or requiring intervention). At the time of reporting the nausea and diarrhea were unresolved. The healthcare professional considered the events were probably related to vaccination with BOOSTRIX.
Producing mucus ball; Vomited; Heart racing; Really dizzy; Difficulty breathing like her lungs were deflating; Coughing; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Heart racing), DIZZINESS (Really dizzy), DYSPNOEA (Difficulty breathing like her lungs were deflating), COUGH (Coughing) and PRODUCTIVE COUGH (Producing mucus ball) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036CZ1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included METOPROLOL, HYDROCHLOROTHIAZIDE, CELECOXIB (CELEBREX), GABAPENTIN, LAMOTRIGINE (LAMICTAL), LEVOCETIRIZINE, OXYBUTYNIN, PANTOPRAZOLE, PRAZOSIN, DESVENLAFAXINE and ACETYLSALICYLIC ACID (ASPIRIN COX [ACETYLSALICYLIC ACID]) for an unknown indication.    On 04-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jun-2021, the patient experienced PALPITATIONS (Heart racing), DIZZINESS (Really dizzy), DYSPNOEA (Difficulty breathing like her lungs were deflating), COUGH (Coughing) and VOMITING (Vomited). On 07-Jun-2021, the patient experienced PRODUCTIVE COUGH (Producing mucus ball). On 04-Jun-2021, VOMITING (Vomited) had resolved. At the time of the report, PALPITATIONS (Heart racing), DIZZINESS (Really dizzy), DYSPNOEA (Difficulty breathing like her lungs were deflating), COUGH (Coughing) and PRODUCTIVE COUGH (Producing mucus ball) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Treatment information was provided.    Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021: Follow - Up document contains No New Information On 05-Aug-2021: Follow up document contains No New Information
Vaccinated Monday morning. Several hours later: malaise that night and Tuesday night chills and sweats. Wednesday morning: rash involving chest, abdomen, back, arms. Itchy.
Patients complains of arm soreness on 11/8/19 with occasional break through bleeding at the injection site. I've referred patient to contact her provider for a follow up on this report. I called patient on 11/15/19 to follow up on patient seeing a provider. She states that the breakthrough bleeding has stopped but her arm is still  sore. She has not made an appointment with her provider yet. States that she is too busy at this time. She states that she will call this nurse back after she sees her provider.
Very sore arm,  fever, nauseous, headache, sniffles. All except armter began  about 18 hours after vaccine. Arm soreness began about 3 hours after.
Patient was inadvertently administered a dose of PROQUAD and VARIVAX on 06/09/2020; Information has been received from a physician referring to a 13 to 14 months old patient of unknown gender. The patient's medical history, concurrent condition and concomitant medication was not provided.      On 09-JUN-2020, the patient was inadvertently administered a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (strength, dose, route, lot # and expiration date were unknown) and varicella virus vaccine live (oka/merck) (VARIVAX) (strength, dose, route, lot # and expiration date were unknown) for prophylaxis (accidental overdose). The outcome of accidental overdose was unknown.
Patient was given her 2nd Pfizer vaccine 9 days before the recommended time between the 1st and 2nd dose. Patient's mother informed of vaccine administration error.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 16Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 57 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Borderline asthma" (unspecified if ongoing). Concomitant medication(s) included: VITAMIN B12 NOS, start date: 01Apr2022, stop date: 10May2022. Past drug history included: Amoxicillin, reaction(s): "Allergy:Amoxicillin"; Alleve, reaction(s): "Allergy:Alleve"; Advil, reaction(s): "AllergyAdvil". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "recovered" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical Course: Adverse event: Bitter taste 24/7 for full 5 days. Return of mild Covid symptoms 6-8 days after completing treatment (minor sore throat, cough, minor lung congestion)  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
7AM 15AUG93 in crib on vacation, cough mom heard scratching sound; mom went to check & pt was tensing & relaxing in convuls for 2 mins; limp, t101;
I was alright 24 hours of my first shot. I believe it was the night of the day after, my body started itching. I thought it was just regular itchiness from my bed or something. But the rashes lasted for about 2 weeks and got worst and concentrated on the mid section of my body the first week. By the 2nd week, I started having little rashes on my fingers, ankles and upper feet. I took anti allergy pills to help with inflammation and helped a little.  Note: I started taking my birth control pills 2 days after vaccination. And also had to take UTI medication for about 3 days (also 2 days after vaccination).
Patient developed a diffuse, bilateral, fine pink rash that was raised, red, and itching.  Physician's impression was typical allergic dermatitis.  Patient given prescription of Atarax 25mg.
Initial unsolicited report received from a nurse 21 July 2015. A female patient (age not reported), whose medical history and concomitant medications were not reported, had received a dose of TDAP VACCINE (batch number, route, dose in series not reported) in left deltoid and also received a dose of MCV4 (batch number not reported) in left deltoid on an unspecified date. On an unspecified date after the vaccination the patient experienced redness, swelling and pain at the injection site. The patient was vaccinated at a clinic. Laboratory investigations and corrective treatments were not reported. At the time of this report the event outcome was not reported. Documents held by sender: none.
Transitory neurological symptoms. Between 3:00 and 4:00 p.m. on 4/30/21, could only read parts of words, could not read the time, could not remember specific personal information (address, insurance, etc.) Admitted to Emergency Department to be tested for stroke. CT scan, EKG, MRI all clear.
flu like symptoms x 48hrs after receiving the 2nd dose of the COVID vaccine.; This is a spontaneous report from a non-contactable pharmacist. A 52-years-old male patient received BNT162B2, (Solution for injection, Batch/Lot Number and Expiration Date was not reported) via an unspecified route of administration on 03Feb2021 05:00 as second dose, single dose for COVID-19 immunization. The patient medical history was not reported. Patient previously received BNT162B2 vaccine. Concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. It was unknown if covid tested post vaccination. It was unknown if other vaccine given in four weeks. The patient experienced flu like symptoms x 48hrs after receiving the 2nd dose of the covid vaccine on 03Feb2021 12:00. It was unknown if treatment was given. The outcome of the event was recovered on Feb2021.  No follow-up attempts are possible. Information about Lot/Batch could not be obtained. No further information is expected.
Redness & swelling at injection sites.Low grade temp - 99.0. Fussy and irritable
mild myocarditis (tight hear muscle) in day time tightness gets stronger usually at night, causes discomfort in sleeping
Developed fever to 103, chills, headache, extreme pain in the right arm where the injection was given, and spreading erythema down the arm. Hospitalized for tachycardia and monitoring and needed IV fluids. Remained with low grade fever for 3 days, and feeling fatigued and "out of it." Redness gradually subsiding as of 1/19.
headaches for 9 days starting on 6/6/2021 - 6/14/2021
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 24 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 18Nov2021 (Lot number: FF8P41) at the age of 24 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose 2, single, lot number:EL3247, expiry date was not reported, at left arm), administration date: 19Feb2021, when the patient was 23 years old, for COVID-19 immunization; Bnt162b2 (Dose 1, single, lot number:EL3247, expiry date not reported, at left arm), administration date: 29Jan2021, when the patient was 23 years old, for COVID-19 immunization.The following information was reported: IMMUNISATION (non-serious) with onset 18Nov2021, outcome "unknown", described as "Third injection/booster"; PYREXIA (non-serious) with onset 19Nov2021, outcome "recovering", described as "feverish"; PAIN (non-serious) with onset 19Nov2021, outcome "recovering", described as "body aches"; CHILLS (non-serious) with onset 19Nov2021, outcome "recovering", described as "chills"; VACCINATION SITE PAIN (non-serious) with onset 19Nov2021, outcome "recovering", described as "sore injection site". Therapeutic measures were not taken as a result of pyrexia, pain, chills, vaccination site pain. Additional information: Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.
Pfizer Bio NTech COVID 19 vaccine EUA-  symptoms began 01/06/21  chills, fever, HA, body aches, N&V
Marble sized lump felt under skin on left size of body where neck and chest meet (lowest part of neck). Painful to touch. Ibuprofen taken - still waiting for lump to disappear.
weird feeling in chest since second dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a patient and describes the occurrence of CHEST DISCOMFORT (weird feeling in chest since second dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CHEST DISCOMFORT (weird feeling in chest since second dose). At the time of the report, CHEST DISCOMFORT (weird feeling in chest since second dose) outcome was unknown.            The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.  Treatment information was not provided by reporter.   Reporter did not allow further contact
her head really aches; dizzy; anxious; upset stomach; weak; body pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558).  A female patient of unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), administration date 09Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious) with onset 2021, outcome "unknown", described as "her head really aches"; DIZZINESS (non-serious) with onset 2021, outcome "unknown", described as "dizzy"; ANXIETY (non-serious) with onset 2021, outcome "unknown", described as "anxious"; ABDOMINAL DISCOMFORT (non-serious) with onset 2021, outcome "unknown", described as "upset stomach"; ASTHENIA (non-serious) with onset 2021, outcome "unknown", described as "weak"; PAIN (non-serious) with onset 2021, outcome "unknown", described as "body pain". Additional Information: The patient received first dose yesterday and was having extremely bad side effects. Reporter stated that, patient (reporter mother) experienced head really aches, very dizzy, very anxious, and had an upset stomach' reporter clarified that her mother was overall Super dizzy, weak, anxious, and was having body pain.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Generalized redness/itchy, rash minutes after flu (urticaria/generalized erythema).